| Autor: |
Hebert, Kathy, Beltran, Julieta, Tamariz, Leonardo, Julian, Elyse, Dias, Andre, Trahan, Pat, Arcement, Lee |
| Předmět: |
|
| Zdroj: |
Congestive Heart Failure (15275299); Jul/Aug2010, Vol. 16 Issue 4, p175-180, 6p, 2 Charts, 4 Graphs |
| Abstrakt: |
The Hispanic population is the fastest growing minority in the United States, yet there is a paucity of data regarding patient follow-up in heart failure disease management programs (HFDMPs) and evidence-based medication adherence. The purpose of this study is to measure the compliance of evidence-based medication use, specifically measuring angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and β-blockers (BBs) in the Hispanic population, and compare these data to the white and black population. The authors conducted a cross-sectional study of 561 patients enrolled in an HFDMP at Jackson Medical Hospital in Miami, Florida. At the first visit, 82% of Hispanic, 75% of white, and 79% of black patients were taking ACEIs/ARBs, but only 21% of Hispanic, 35% of white, and 32% of black patients were taking target doses. Hispanic patients are as compliant with ACEI/ARB and BB regimens as are the white and black populations in HFDMPs in a setting of similar socioeconomic features. Congest Heart Fail. 2010;16:175–180. © 2010 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text